Revenue · 2014–2025

Akebia Therapeutics revenue

$236M+47.5% · FY2025

Akebia Therapeutics (AKBA) reported $236M in revenue for fiscal 2025, +47.5% year on year.

$02014$02015$1.5M2016$181M2017$208M2018$335M2019$295M2020$212M2021$292M2022$195M2023$160M2024$236M2025
Akebia Therapeutics — Revenue, 2014–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$236M+47.5%Open →
FY20242024-12-31$160M−17.7%Open →
FY20232023-12-31$195M−33.5%Open →
FY20222022-12-31$292M+38.2%Open →
FY20212021-12-31$212M−28.2%Open →
FY20202020-12-31$295M−12.0%Open →
FY20192019-12-31$335M+61.3%Open →
FY20182018-12-31$208M+14.6%Open →
FY20172017-12-31$181M+11,706.3%Open →
FY20162016-12-31$1.5M+$1.5MOpen →
FY20152015-12-31$0$0Open →
FY20142014-12-31$0—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Akebia Therapeutics revenue |url=https://companiesranked.com/en/company/akebia-therapeutics/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Akebia Therapeutics revenue. CompaniesRanked. https://companiesranked.com/en/company/akebia-therapeutics/revenue

BibTeX

@misc{companiesranked-en-company-akebia-therapeutics-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Akebia Therapeutics revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/akebia-therapeutics/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001517022-26-000020 · February 26, 2026

{{cite web |title=Akebia Therapeutics revenue — 10-K (0001517022-26-000020) |url=https://www.sec.gov/Archives/edgar/data/1517022/000151702226000020/akba-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Akebia Therapeutics overview